4893 results
-
List item
News: EMA starts rolling review of Celltrion antibody regdanvimab for COVID-19
Last updated: 24/02/2021 -
List item
Technical workshop on real-world metadata for regulatory purposes (updated)
Virtual meeting, 12/04/2021, Last updated: 23/02/2021 -
List item
Paediatric Committee (PDCO): 23-26 February 2021 (updated)
Virtual meeting, from 23/02/2021 to 26/02/2021, Last updated: 23/02/2021 -
List item
News: EMA starts evaluating use of Veklury in COVID-19 patients not requiring supplemental oxygen
CHMP, Last updated: 23/02/2021 -
List item
Public stakeholder meeting: approval, safety monitoring and impact of COVID-19 vaccines in the EU
Virtual meeting, 13:00 - 15:15 (CET), 26/03/2021, Last updated: 22/02/2021 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-17 February 2021
CVMP, Last updated: 19/02/2021 -
List item
SME and academia Clinical Trials Information System (CTIS) two-part training webinar - Day 1 (updated)
Virtual event, 22/02/2021, Last updated: 18/02/2021 -
List item
News: Precautionary marketing suspension of thalassaemia medicine Zynteglo
Last updated: 17/02/2021 -
List item
News: EMA receives application for conditional marketing authorisation of COVID-19 Vaccine Janssen
Last updated: 16/02/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 16-18 February 2021 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 16/02/2021 to 18/02/2021, Last updated: 16/02/2021 -
List item
European Medicines Agency (EMA) Patients' and Consumers'(PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting
Virtual meeting, from 02/03/2021 to 03/03/2021, Last updated: 16/02/2021 -
List item
Committee for Advanced Therapies (CAT): 17-19 February 2021 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 17/02/2021 to 19/02/2021, Last updated: 16/02/2021 -
List item
SME and academia Clinical Trials Information System (CTIS) two-part training webinar - Day 2 (updated)
Virtual event, 04/03/2021, Last updated: 15/02/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 February 2021
PRAC, Last updated: 12/02/2021 -
List item
News: EMA starts rolling review of CureVac’s COVID-19 vaccine (CVnCoV)
Last updated: 12/02/2021 -
List item
News: EMA preparing guidance to tackle COVID-19 variants
Last updated: 10/02/2021 -
List item
News: Clarification on Sputnik V vaccine in the EU approval process
Last updated: 10/02/2021 -
List item
Third EMA-EFPIA annual bilateral meeting
Virtual meeting, 10/02/2021, Last updated: 10/02/2021 -
List item
News: International regulators working together to enhance collaboration on COVID-19 observational research
Last updated: 08/02/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2021 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 08/02/2021 to 11/02/2021, Last updated: 08/02/2021 -
List item
News: EMA reviewing data on monoclonal antibody use for COVID-19
Last updated: 04/02/2021 -
List item
News: EMA COVID-19 assessments ‘OPEN’ to non-EU regulators
Last updated: 04/02/2021 -
List item
News: EMA starts rolling review of Novavax’s COVID-19 vaccine (NVX-CoV2373)
Last updated: 03/02/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 19-21 January 2021 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 19/01/2021 to 21/01/2021, Last updated: 03/02/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 3-5 November 2020 (updated)
Virtual meeting, from 03/11/2020 to 05/11/2020, Last updated: 03/02/2021